CPT code 32606 represents a thoracoscopic endoscopic procedure to visualize the thorax and obtain a mediastinal tissue sample for pathological evaluation. This procedure is an important diagnostic tool in the evaluation of mediastinal masses, lymphadenopathy, and staging of thoracic malignancies. Nationally, accurate coding and documentation for thoracoscopic mediastinal sampling affect clinical decision-making, quality measurement, and reimbursement pathways.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for this procedure, typical sites of service, and payer coverage landscape. The publication outlines common billing considerations, relevant modifiers provided in the input, and guidance on where clinical documentation should support the code selection. It also summarizes benchmark elements and policy updates where available and identifies gaps when input data are not provided.

This summary is intended for a national audience of coding professionals, practice managers, and clinicians seeking a clear overview of CPT code 32606, its clinical role, and the payer context that influences billing and coverage practices.